SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-014940
Filing Date
2009-03-09
Accepted
2009-03-09 17:38:51
Documents
1
Period of Report
2009-03-05

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c82255_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c82255_4x0.xml 4 3662
  Complete submission text file 0001209191-09-014940.txt   5485
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 435 TASSO STREET SUITE 200 PALO ALTO CA 94301
Business Address 650-470-8116
TANANBAUM JAMES B (Reporting) CIK: 0001162061 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 09667209